Rigel Pharmaceuticals Inc — Cash Flow (NASDAQ:RIGL) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics Dividends

Quarterly Annual

Cash from operating activities 52.19 M5.88 M73.76 M5.74 M31.47 M 68.18 M Cash from investing activities 47.47 M80.04 M72.78 M4.3 M4.13 M 56.09 M Cash from financing activities 12.57 M62.67 M6.55 M18.37 M11.64 M 3.71 M Free cash flow 50.92 M5.25 M73.31 M-9.26 M31.11 M 68.18 M

Haberler

Earnings Preview: Profound Medical (PROF) Q4 Earnings Expected to Decline

Xencor (XNCR) Reports Q4 Loss, Tops Revenue Estimates

Rigel Pharmaceuticals (RIGL) Earnings Expected to Grow: Should You Buy?

IOVA vs. RIGL: Which Small-Cap Biotech Has More Upside Potential?

Will Tavalisse Continue to Drive Rigel Pharmaceuticals' Growth in 2026?

RIGL Stock Rises 59% in a Year: Time to Buy, Hold or Sell?

FOLD vs. RIGL: Which Rare Disease Biotech Stock Has Better Upside?

Rigel Pharmaceuticals: Continued Financial Performance, Catalysts In 2026 (RIGL)

Profound Medical (PROF) Soars 9.5%: Is Further Upside Left in the Stock?

Rigel Pharmaceuticals, Inc. (RIGL) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

CNC Deepens Medicaid Strategy With Cityblock Partnership in Illinois

Zacks Industry Outlook Highlights Soleno Therapeutics, Nektar Therapeutics, Rigel Pharmaceuticals, Ironwood Pharmaceuticals and Marker Therapeutics